Transcatheter Cardiovascular Therapeutics (TCT)

The Transcatheter Cardiovascular Therapeutics (TCT) conference is the Cardiovascular Research Foundation's (CRF) annual scientific symposium and the largest conference focused on interventional cardiovascular medicine. TCT includes seminars on all areas of intervention cardiology, structural heart, vascular in interventions, peripheral artery disease, and other procedures in the cath lab.

Cardiologist shares his long journey from Libya to United States
Abdel Almanfi, MD, went through years of training in Libya, but then he had to start over once he landed in the United States.
Cardiologists share historic research that led to FDA’s long-awaited approval of coronary DCB
When Boston Scientific’s coronary DCB gained approval in the United States, it was a moment the country's cardiologists had been looking forward to for years. The cardiologists who researched the device have now detailed their findings, highlighting the "unmet need" this technology is addressing.
Why financial literacy is so important for structural heart program directors
Carrie Redick, an ICU nurse for nearly 20 years, said understanding more about financial data improved her ability to acquire funding and other resources for her program when necessary.
Data registries have been a huge success for U.S. structural heart programs
ACC/STS National Cardiovascular Data Registry metrics reporting for TAVR is important for marketing and care quality, explains Patricia Keegan, NP, with the Emory Heart and Vascular Center.
CroíValve kicks off early feasibility study for new TR device, names cardiologist Martin Leon to advisory board
The company hopes to enroll 15 patients to monitor the safety and effectiveness of its new-look transcatheter device for severe tricuspid regurgitation.

Driven by its strategic goal to advance equity in the U.S. healthcare innovation sector, the American Medical Association (AMA) recently announced an initiative that supports leading industry stakeholders in committing to equitable health innovation opportunities targeted to improving health outcomes in historically marginalized communities. #Healthdisparities

Bivalirudin bests heparin for treating heart attack patients undergoing PCI

The findings were presented Wednesday, Oct. 14, during TCT Connect 2020.

October 14, 2020

TCT 2020 to be held virtually due to COVID-19 concerns

TCT 2020, now known as TCT Connect, is scheduled to broadcast Oct. 14-18, 2020.

May 27, 2020

Orsiro stent continues to outperform Xience at 3 years

Three-year data from the BIOFLOW-V trial, presented Feb. 23 at the 2020 CRT Congress in National Harbor, Md., reinforce the status of Biotronik’s Orsiro drug-eluting stent as superior to the popular Xience stent.

February 26, 2020

Study reveals similar 5-year outcomes for TAVR, SAVR

An analysis of PARTNER 2 data published in the New England Journal of Medicine Jan. 29 suggests five-year post-op outcomes are similar among heart patients who undergo either transcatheter or surgical aortic valve replacement.

January 30, 2020

Cardiology’s Challenge for the 2020s: Turning the Trend on Rising Mortality

The latest numbers on cardiovascular deaths put the focus on innovative ways to point the trend line down again.

November 1, 2019

UFR-guided hydration minimizes contrast-induced complications in CKD patients

Urine flow rate-guided hydration, as opposed to left ventricular end-diastolic pressure-guided hydration, could prevent more complications in CKD patients who are at a high risk for contrast-induced kidney injury.

October 15, 2019

Ticagrelor alone reduces bleeding risk after PCI, DAPT

Results from the late-breaking TWILIGHT trial suggest that, among high-risk patients who have undergone PCI and completed three months of dual antiplatelet therapy, it’s safer to continue treatment with ticagrelor alone rather than add aspirin to that cocktail.

October 9, 2019

TAVR linked to better long-term health status than SAVR

Patients with severe aortic stenosis who undergo TAVR enjoy a minor but significant sustained health benefit that isn’t mirrored in patients who opt for surgical AVR, according to research reported at TCT 2019 in San Francisco.

October 3, 2019

Transcatheter Cardiovascular Therapeutics (TCT)

Cardiologist shares his long journey from Libya to United States

Cardiologists share historic research that led to FDA’s long-awaited approval of coronary DCB

Why financial literacy is so important for structural heart program directors

Data registries have been a huge success for U.S. structural heart programs

CroíValve kicks off early feasibility study for new TR device, names cardiologist Martin Leon to advisory board